ER/LA Opioids: Evidence Based Management Tools and Specific Drug Information

This program is developed through a providership between the University of North Texas Health Science Center and Antidote Education Company.

This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies.  Please see for a listing of the member companies.  This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.

Release date: February 27, 2015

Valid through: February 27, 2016

Specialty: Primary Care

Estimated Time to Complete: 60 minutes

Target Audience

This activity is intended to educate primary care and specialist providers who treat patients with chronic pain.

Program Overview

This session is the third in a four part series on managing chronic pain with extended release and long-acting opioids.  . 

This webinar will focus on specific evidence-based tools for managing ongoing opioid therapy. This includes information on patient adherence monitoring and managing adverse effects. Drs. Charles Argoff and Steven Stanos will provide a review of individual ER/LA opioid therapies.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  1. Be knowledgeable about how to manage ongoing therapy with ER/LA opioid analgesics.
  2. Be familiar with general and product-specific drug information concerning ER/LA opioid analgesics.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ , 1.0 AOA Category 2B CME Credits, and/or 1.0 AAFP Prescribed Credit.
  • Nurse Practitioners — AANP Credit
  • Physician Assistants — AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™  from organizations accredited by ACCME or a recognized state medical society.

All other healthcare professionals completing this course will be issued a statement of participation.


Charles E. Argoff, MD

Dr. Argoff is Professor of Neurology at Albany Medical College and Director of the Comprehensive Pain Center at Albany Medical Center in New York. Dr. Argoff is a member of the American Academy of Neurology, the International Association for the Study of Pain, the American Academy of Pain Medicine, and the American Pain Society, among other professional organizations. He is the President of the American Academy of Pain Medicine Foundation Board. Dr. Argoff is one of the editors of the recently published texbook, Raj's Practical Management of Pain, Fifth Edition. He is the co-author of Defeat Chronic Pain Now, a just published book for people with chronic pain. He has recently published the third edition of Pain Management Secrets.

Steven Stanos, DO

Dr. Stanos is currently Medical Director of Occupational Medicine Services at Swedish Spine, Sports, and Musculoskeletal Medicine, Swedish Medical Group and an attending physician in the Pain and Headache Clinic at Swedish Medical Center in Seattle, Washington. At Swedish, in addition to overseeing occupational medicine services, he is working to develop a pain rehabilitation continuum of care for the Swedish Medicine and Providence Health System. From 2002 to 2014 Dr Stanos served as medical director of the Center for Pain Management at the Rehabilitation Institute of Chicago (RIC), as well as directing workers compensation medical services for the hospital system. While in Chicago, he was an Associate Professor in the Department of Physical Medicine and Rehabilitation and Assistant Program Director of the Multidisciplinary Pain Fellowship at Northwestern University Feinberg School of Medicine.

He is board certified in physical medicine and rehabilitation and pain medicine by the American Board of Pain Medicine and subspecialty boarded by the American Board of Anesthesia.

Dr. Stanos presently serves on the Board of Directors and as Treasurer of the American Academy of Pain Medicine. He is active with the American Academy of Physical Medicine and Rehabilitation, and has served as the co-chair of education for the Pain and Neuromuscular Council and as a panel member on the academy's Opioid Risk Evaluation Mitigation Strategies (REMS) task force. He is active on a number of committees for the American Pain Society and the Midwest Pain Society where he serves on the board of directors.

Dr. Stanos received his BA in psychology from the University of Cincinnati and DO degree from Nova Southeastern University in Miami, FL. He completed an internship in the Department of Medicine at Chicago Osteopathic Hospitals & Medical Centers, a PM&R residency at the Rehabilitation Institute of Chicago, and a pain fellowship at the Northwestern University School Feinberg School of Medicine.

Accreditation Statement

The University of North Texas Health Science Center at Fort Worth is accredited by the American Osteopathic Association to award continuing medical education to physicians.

The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 4 hours of AOA Category 2B CME credits.  Approval is currently pending.

The University of North Texas Health Science Center at Fort Worth designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Enduring Material activity, Effective Strategies for Chronic Pain Management: Assessing Patients for Treatment has been reviewed and is acceptable for up to 4.0 Prescribed credits by the American Academy of Family Physicians. Term of approval begins 2/27/2015.  Term of approval is for one year from this date. Each webcast is approved for 1.0 Prescribed credit. Credit may be claimed for one year from the date of each webcast. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is approved for 4.0 contact hour(s) of continuing education (which includes 2.28 hours of pharmacology) by the American Association of Nurse Practitioners.  Program ID 1411483. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit from organizations accredited by ACCME.

Disclosures of Conflicts of Interest

The University of North Texas Health Science Center (UNTHSC) and Antidote Education Company (Antidote) are committed to creating, developing, and operating high-quality, relevant, and practical continuing medical education activities that are in compliance with the ACCME's policies on commercial support and disclosure. Specifically, we are dedicated to ensuring that our activities are planned and implemented free of the control of commercial interests and to identifying and resolving conflicts of interest of all persons in a position to control the content of an educational activity before the educational activity occurs.

Individuals in a position to control the content of this CME activity reported the following relevant financial relationships with commercial interests:

Charles Argoff, MD
Research: Endo Pharmaceuticals
Consultant: Pfizer, Teva Pharmaceutical Industries, Ltd., Daiichi Sankyo, Janssen Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Purdue, Zogenix Inc., Nektar Therapeutics
Speaker: Janssen Pharmaceuticals, Inc.

Steven Stanos, DO
Consultant/Received Honoraria: Pfizer, Mallinckrodt Pharmaceuticals, MyMatrixx, Zogenix Inc.

All UNTHSC and Antidote staff members and others involved in the planning, development and review of the content of this activity have no relevant conflicts of interest to disclose.

Instructions for Participation and Credit

This activity is comprised of 4 sessions.  Each session will take approximately 60 minutes to complete.  To receive credit, participants are required to complete the pre-test, view the online video and complete the post-test and evaluation form.  To receive credit, a minimum score of 70% must be achieved on the post-test.  A certificate will be immediately available.  There is no fee to participate in the activity or for the generation of a certificate.


Internet streaming video

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.

Disclosure of Unlabeled Use

This activity does not include intentional, prescribed unlabeled use of pharmaceuticals.  There is discussion of the consequences of drug misuse.


The University of North Texas Health Science Center presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.


This educational program and its content are copyright 2014-2015 by Antidote Education Company and the University of North Texas Health Science Center.